At a glance
ClinicalIndex Comparison RecordN/ACompleted· 344 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prognostic Role of Persistent Microvascular Obstruction by Cardiac Magnetic Resonance for ST-segment Elevation Myocardial Infarction
In Brief
An observational study for ST Elevation (STEMI) Myocardial Infarction. Completed, enrolled 344 participants across 1 site.
Detailed Summary
The aims of the study were to evaluate the predictive value of persistent microvascular obstruction (MVO) by cardiac magnetic resonance for main adverse cardiac events in ST-segment elevation myocardial infarction patients. MVO in the acute phase of myocardial infarction has been considered to be strong predictor of a poor prognosis. We plan to explore the relationship between persistent MVO and the long-term prognosis of patients with STEMI. We made hypothesis that patients with persistent MVO have a poor prognosis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartApr 2017
Primary CompletionJul 2024
Study CompletionOct 2024
First PostedJan 2025
TodayJul 2026
First PostedJan 6, 2025
Enrollment StartApr 1, 2017
Primary CompletionJul 20, 2024
Study CompletionOct 20, 2024
TodayJul 2, 2026
Enrollment to primary: 7.3 yearsPosted 1.5 years ago